eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
4.110
0.00 (0.00%)
Oct 30, 2026, 9:46 AM EDT - Market open
eXoZymes Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
38.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 70.07K | 41.47K | 145.01% |
| Dec 31, 2022 | 28.60K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
EXOZ News
- 8 days ago - eXoZymes CEO to Discuss Commercialization, Key Milestones, and Potential Catalysts in Fireside Chat with Water Tower Research - Accesswire
- 24 days ago - eXoZymes Slides: Investor presentation - Filings
- 27 days ago - Water Tower Research Publishes Initiation of Coverage Report on eXoZymes, Inc., "Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity" - TheNewswire
- 4 weeks ago - eXoZymes Proxy statement: Proxy filing - Filings
- 4 weeks ago - eXoZymes Proxy statement: Proxy filing - Filings
- 7 weeks ago - eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCT - Accesswire
- 2 months ago - eXoZymes Inc trading resumes - TheFly
- 2 months ago - eXoZymes Inc trading halted, volatility trading pause - TheFly